IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.
Multiple myeloma is a cancer that forms in a type of white blood cell called a plasma cell. Healthy plasma cells help you fight infections by making antibodies that recognize and attack germs. In multiple myeloma, cancerous plasma cells accumulate in the bone marrow and crowd out healthy blood cells. Treatment depends on stage:- Treatments include medication, chemotherapy, corticosteroids, radiation or a stem-cell transplant.
The following lists anti-cancer drugs, US FDA and Indian Generic brand approved by the Food and Drug Administration (FDA) for Multiple Myeloma treatment. The list includes generic and brand names are in some way related to, or used in the treatment of this condition. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
ALKERAN ® (melphalan hydrochloride) for Injection Initial U.S. Approval: 2001
More Details...BRAFTOVI ™ (encorafenib) capsules, for oral use. Initial U.S. Approval: 2018.
More Details...Bortenat (bortezomib) for Injection. For intravenous use. Initial U.S. Approval: 2003
More Details...CALQUENCE ® (acalabrutinib) capsules, for oral use Initial U.S. Approval: 2017
More Details...DARZALEX (daratumumab) injection, for intravenous use. Initial U.S. Approval – 2015
More Details...FARYDAK ® (panobinostat) capsules, for oral use. Initial U.S. Approval: 2015
More Details...KEYTRUDA ® (pembrolizumab) injection, for intravenous use. Initial U.S. Approval: 2014
More Details...KYPROLIS ™ (carfilzomib) for Injection, for intravenous use Initial U.S. Approval: 2012
More Details...MYLOTARG (gemtuzumab ozogamicin) for injection, for intravenous use. Initial U.S. Approval: 2000
More Details...SARCLISA ® (isatuximab-irfc) injection, for intravenous use Initial U.S. Approval: 2020
More Details...VELCADE ® (bortezomib) for injection, for intravenous use. Initial U.S. Approval: 2003
More Details...Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi, New Delhi:110016 India.
We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.
Indian Pharma Network is registered medical pharmacy for Oncology Products in India.Helps you to access FDA approved Multiple Myeloma medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Multiple Myeloma Medicines in China, UAE, Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
If you have a question relating to anti-cancer medicines approved for treatment of Multiple Myeloma, a problem which you do not know how to resolve it, or concrete inquiry - we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.
The list includes US FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.
IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.
The list includes US FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.
IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.
The list includes FDA approved brand drugs names are in some way related to, or used in the treatment of this condition.
IPN, New Delhi can facilitate patient to import of "Oncology Products" for personal use under "patient name basis" treatment in India.